Media Center

Elastrin's Chief Scientific Officer Prof. Naren Vyavahare was granted USD 2.2 million from the National Institutes of Health to advance his research on reversing calcification by use of targeted nanoparticles. As Hunter Endowed Chair of Bioengineering at Clemson University and Director of the Bioengineering Center for Regeneration and Formation of Tissues (SC BioCRAFT) Prof. Vyavahare has a long standing relationship with the NIH that goes back more than two decades. Credit:

The South Carolina Research Authority (SCRA) has granted Elastrin $25.000 in financial support through its Academic Start-up Assistance Program (ASAP), showing confidence in our technology. SCRA is a public, non-profit corporation by the State of South Carolina that fosters South Carolina’s Innovation Economy by supporting entrepreneurs, enabling academic research and its commercialization, and connecting innovators to industry. On behalf of their entrepreneurial program SC L

Elastrin Therpapeutics has won the 2018 Xi´an International Entrepreneuship Competition held in Hamburg October 19, 2018 and was selected with four other startups from Germany to be invited to the finals. Chief Medical Officer Dr. med. Anne Thews delivered a presentation that convinced the jury consisting of various start-up and industry experts of the great potential our nanoparticle platform possesses for effective treatment of life-threatening diseases in over 40 Mio pa